![]() |
| Dr Pablo Casillas-Espinosa |
Dr Pablo Casillas-Espinosa was awarded the 2018 Suzanne and Peter Berry International Travel Award, whilst Dr Rhys Brady received the 2018 Young Investigator Award.
![]() |
| Dr Pablo Casillas-Espinosa |
![]() |
| Could your research be the next big thing on The Conversation? |
![]() |
| MAPrc PhD student Elizabeth Thomas with her baby daughter |
![]() |
| Dr Carolyn Breadon, PhD candidate at MAPrc,11.30 am Mon 10 Sep |
| Mon | 10/09/2018 | ► | 11:30 | PhD confirmation milestone - Carolyn Breadon |
| ► | 12:00 | Neuroscience seminar series CANCELLED | ||
| Tue | 11/09/2018 | ► | 11:00 | MPhil Confirmation Milestone: Ing Tiong |
| Wed | 12/09/2018 | ► | 11:30 | Seminar: Christina Begka |
| Thur | 13/09/2018 | ► | 11:30 | Journal Club: Jade Jaffar |
| 12:00 | Alfred Grand Rounds: Controversies in aged care |
![]() |
| ACBD research group working on leukaemia stem cells. L-R: Ms Loretta Cerruti, A/Prof Stephen Ting, Ms Jacqueline Boyle, A/Prof David Curtis, Dr Cedric Tremblay, Dr Stefan Sonderegger, Dr Emma Toulmin, Dr Christina Tebartz, Ms Jesslyn Saw, Mr Andrej Terzic, Ms Michelle Karlik, Ms Ashlee Conway. The bolded names are co-authors on a recent paper investigating pre-leukaemia stem cell mutations. Cure rates for acute leukemia have not improved over the last 20 years. One explanation for this lack of progress is the existence of rare leukemic cells that escape chemotherapy. Using genetically modified mice that can track cells according to their cycling kinetics, we found that dormant leukemic cells are essential for the progression of the disease. Most importantly, we show that these dormant cells escape chemotherapy and lead to recurrence of the disease in acute leukemia. This work will identify new ways to eliminate these therapy-resistant cells and improve cure rates for patients with acute leukemia. |